R
Ronald C. Savin
Researcher at Yale University
Publications - 48
Citations - 3469
Ronald C. Savin is an academic researcher from Yale University. The author has contributed to research in topics: Terbinafine & Hair loss. The author has an hindex of 32, co-authored 48 publications receiving 3299 citations. Previous affiliations of Ronald C. Savin include Columbia University & Harvard University.
Papers
More filters
Journal ArticleDOI
Finasteride in the treatment of men with androgenetic alopecia
Keith D. Kaufman,Elise A. Olsen,David A. Whiting,Ronald C. Savin,Richard L. DeVillez,Wilma F. Bergfeld,Vera H. Price,Dominique Van Neste,Janet L. Roberts,Maria K. Hordinsky,Jerry Shapiro,Bruce Binkowitz,Glenn J. Gormley +12 more
TL;DR: In men with male pattern hair loss, finasteride 1 mg/d slowed the progression of hair loss and increased hair growth in clinical trials over 2 years.
Journal ArticleDOI
Psychological effects of androgenetic alopecia on women: Comparisons with balding men and with female control subjects*
TL;DR: The results confirm the psychologically detrimental effects of androgenetic alopecia, especially on women, and the implications for patient care are discussed.
Journal ArticleDOI
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
Vera H. Price,Janet L. Roberts,Maria K. Hordinsky,Elise A. Olsen,Ronald C. Savin,Wilma F. Bergfeld,Virginia C. Fiedler,Anne W. Lucky,David A. Whiting,Frances Pappas,Jennifer Culbertson,Paul Kotey,Alan G. Meehan,Joanne Waldstreicher +13 more
TL;DR: In postmenopausal women with AGA, finasteride 1 mg/day taken for 12 months did not not increase hair growth or slow the progression of hair thinning.
Journal ArticleDOI
Topical tretinoin for treatment of photodamaged skin. A multicenter study.
Gerald D. Weinstein,Thomas P. Nigra,Peter E. Pochi,Ronald C. Savin,A Allan,K Benik,E Jeffes,L Lufrano,E G Thorne +8 more
TL;DR: Clinical and histologic effects of a new emollient cream formulation of topical tretinoin at concentrations of 0.05% and 0.01% provide independent evidence supporting clinical improvement and side effects were usually mild and well tolerated.
Journal ArticleDOI
A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Anne W. Lucky,Daniel Piacquadio,Chérie M. Ditre,Frank Dunlap,Irwin Kantor,Amit G. Pandya,Ronald C. Savin,Michael D. Tharp +7 more
TL;DR: 5% topical minoxidil was superior to placebo on each of the 3 primary efficacy end points: promoting hair growth as measured by change in nonvellus hair count and patient/investigator assessments of hair growth and scalp coverage.